Health Secretary Robert F. Kennedy Jr. endured a bruising first test on Capitol Hill Thursday as Congress dug into roughly $16 billion in proposed cuts to the Department of Health and Human Services (HHS) and probed his vaccine positions.
Quick snapshot
- Trump administration’s 2027 budget requests $111.1 billion in HHS discretionary spending — a 12.5% cut from 2026.
- The proposal trims about $16 billion across HHS, including a contested $5 billion reduction to the National Institutes of Health (NIH).
- Kennedy faces a week of hearings: Thursday’s Ways and Means session was followed by an Appropriations subcommittee hearing and at least seven appearances across both chambers; he’s also slated to testify before the Senate Finance and HELP Committees on April 22.
What happened in the hearing
Kennedy framed the cuts as a deliberate “structural shift” away from existing federal strategies, saying his agenda aims to “put the health of Americans first” and to reverse policies he blames for a chronic disease rise. But lawmakers from both parties pressed him hard on specifics.
The NIH cut — the largest single line item under fire — drew bipartisan pushback. Members warned that reducing NIH funding could slow basic medical research at universities and private labs, with downstream effects on drug development and scientific innovation.
Kennedy was unusually candid about his discomfort with certain Trump budget priorities, saying he was “not happy” about proposed reductions to nutrition programs like WIC and SNAP. Rep. Gwen Moore pressed him on how those cuts square with his stated goal of fighting childhood chronic disease; Kennedy did not offer a concrete fix.
Vaccine questions and optics
Vaccine policy dominated parts of the questioning, but Kennedy largely dodged detailed engagement. Republican Rep. Tim Murphy used the moment to attack former NIAID Director Anthony Fauci, while Democratic Rep. Linda Sánchez delivered a memorable rebuke: she criticized Kennedy for suspending a pro-vaccine messaging campaign even as HHS paid for a promotional video showing him shirtless in a hot tub with Kid Rock.
Political calculus and intra-administration friction
The hearings come amid signs of strain within Kennedy’s MAHA coalition and caution from the White House. Advisers have reportedly told Kennedy and HHS officials to avoid publicly pushing controversial vaccine reforms until after the November midterms — suggesting some of his positions are seen as electoral liabilities.
Kennedy’s performance carries career risk as well as policy consequences. The White House has shown little tolerance for officials who struggle before Congress, and observers are watching to see if he can withstand sustained bipartisan scrutiny.
Wider implications: research, AI pipelines and policy bandwidth
Beyond optics, the NIH funding cut has concrete implications: reduced federal support could slow AI-driven medical research pipelines that have expanded with recent federal grants. That matter intersects with broader agenda battles on the Hill — from FISA reauthorization to budget reconciliation and the CLARITY Act — all competing for limited legislative bandwidth in a politically compressed calendar.
For crypto watchers, the hearing is also a reminder of how the midterm calendar shapes messaging and regulatory moves across the administration. The same political timeline that has Kennedy tamping down controversial public stances is influencing how the White House and agencies approach high-profile issues from healthcare to crypto regulation.
Bottom line
Thursday’s hearings were an early, high-stakes gauge of whether Kennedy can defend major budget cuts and controversial policy positions under bipartisan scrutiny. The fate of NIH funding, nutrition programs, and vaccine messaging — plus the broader signal sent to agency officials and regulated industries — will play out in the week’s marathon of hearings and in the policy fights to come.
Read more AI-generated news on: undefined/news
